Cargando…
Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3–23 days since the first symptoms. The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a s...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096774/ https://www.ncbi.nlm.nih.gov/pubmed/32209163 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.11.2000266 |
| _version_ | 1783510908830482432 |
|---|---|
| author | Haveri, Anu Smura, Teemu Kuivanen, Suvi Österlund, Pamela Hepojoki, Jussi Ikonen, Niina Pitkäpaasi, Marjaana Blomqvist, Soile Rönkkö, Esa Kantele, Anu Strandin, Tomas Kallio-Kokko, Hannimari Mannonen, Laura Lappalainen, Maija Broas, Markku Jiang, Miao Siira, Lotta Salminen, Mika Puumalainen, Taneli Sane, Jussi Melin, Merit Vapalahti, Olli Savolainen-Kopra, Carita |
| author_facet | Haveri, Anu Smura, Teemu Kuivanen, Suvi Österlund, Pamela Hepojoki, Jussi Ikonen, Niina Pitkäpaasi, Marjaana Blomqvist, Soile Rönkkö, Esa Kantele, Anu Strandin, Tomas Kallio-Kokko, Hannimari Mannonen, Laura Lappalainen, Maija Broas, Markku Jiang, Miao Siira, Lotta Salminen, Mika Puumalainen, Taneli Sane, Jussi Melin, Merit Vapalahti, Olli Savolainen-Kopra, Carita |
| author_sort | Haveri, Anu |
| collection | PubMed |
| description | The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3–23 days since the first symptoms. The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins. |
| format | Online Article Text |
| id | pubmed-7096774 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Centre for Disease Prevention and Control (ECDC) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70967742020-03-26 Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 Haveri, Anu Smura, Teemu Kuivanen, Suvi Österlund, Pamela Hepojoki, Jussi Ikonen, Niina Pitkäpaasi, Marjaana Blomqvist, Soile Rönkkö, Esa Kantele, Anu Strandin, Tomas Kallio-Kokko, Hannimari Mannonen, Laura Lappalainen, Maija Broas, Markku Jiang, Miao Siira, Lotta Salminen, Mika Puumalainen, Taneli Sane, Jussi Melin, Merit Vapalahti, Olli Savolainen-Kopra, Carita Euro Surveill Rapid Communication The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3–23 days since the first symptoms. The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins. European Centre for Disease Prevention and Control (ECDC) 2020-03-19 /pmc/articles/PMC7096774/ /pubmed/32209163 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.11.2000266 Text en This article is copyright of the authors or their affiliated institutions, 2020. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
| spellingShingle | Rapid Communication Haveri, Anu Smura, Teemu Kuivanen, Suvi Österlund, Pamela Hepojoki, Jussi Ikonen, Niina Pitkäpaasi, Marjaana Blomqvist, Soile Rönkkö, Esa Kantele, Anu Strandin, Tomas Kallio-Kokko, Hannimari Mannonen, Laura Lappalainen, Maija Broas, Markku Jiang, Miao Siira, Lotta Salminen, Mika Puumalainen, Taneli Sane, Jussi Melin, Merit Vapalahti, Olli Savolainen-Kopra, Carita Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |
| title | Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |
| title_full | Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |
| title_fullStr | Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |
| title_full_unstemmed | Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |
| title_short | Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |
| title_sort | serological and molecular findings during sars-cov-2 infection: the first case study in finland, january to february 2020 |
| topic | Rapid Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096774/ https://www.ncbi.nlm.nih.gov/pubmed/32209163 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.11.2000266 |
| work_keys_str_mv | AT haverianu serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT smurateemu serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT kuivanensuvi serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT osterlundpamela serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT hepojokijussi serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT ikonenniina serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT pitkapaasimarjaana serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT blomqvistsoile serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT ronkkoesa serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT kanteleanu serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT strandintomas serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT kalliokokkohannimari serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT mannonenlaura serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT lappalainenmaija serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT broasmarkku serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT jiangmiao serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT siiralotta serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT salminenmika serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT puumalainentaneli serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT sanejussi serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT melinmerit serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT vapalahtiolli serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 AT savolainenkopracarita serologicalandmolecularfindingsduringsarscov2infectionthefirstcasestudyinfinlandjanuarytofebruary2020 |